In the GA treatment group, the expression of E-cadherin was higher than in the BLM group, while the expression of α-SMA was lower, suggesting that GA may intervene in the EMT process in IPF (Figure 2(a)). The gene discussed is ACTA1; the disease is idiopathic pulmonary fibrosis.